Carregant...

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. However, reliable diagnostic or prognostic tumor markers have not been identified for endometrial cancer. In this study, we examined whether urokinase plasminogen activator receptor (UPAR), a glycosyl-phosphat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Memarzadeh, Sanaz, Kozak, Katherine R., Chang, Lisbeth, Natarajan, Sathima, Shintaku, Peter, Reddy, Srinivasa T., Farias-Eisner, Robin
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2002
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC125001/
https://ncbi.nlm.nih.gov/pubmed/12130664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.152127499
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!